Cite

    Batra, A. et al. (2021). Developing a clinical-pathologic model to predict genomic risk of recurrence in patients with hormone receptor positive, human epidermal growth factor receptor-2 negative, node negative breast cancer. Cancer treatment and research communications. p. . [Online].